Pnc Financial Services Group, Inc. Coherus Bio Sciences, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 327 shares of CHRS stock, worth $258. This represents 0.0% of its overall portfolio holdings.

Number of Shares

327

Previous 98 233.67%

Holding current value

$258

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.81 - $1.66 $185 - $380	229 Added 233.67%	327 $0
Q3 2024 Nov 08, 2024	SELL	$0.99 - $1.8 $174 - $316	-176 Reduced 64.23%	98 $0
Q2 2024 Aug 09, 2024	SELL	$1.58 - $2.51 $644 - $1,024	-408 Reduced 59.82%	274 $0
Q1 2024 May 10, 2024	BUY	$2.02 - $3.14 $258 - $401	128 Added 23.1%	682 $1,000
Q4 2023 Feb 09, 2024	SELL	$1.59 - $3.85 $6,364 - $15,411	-4,003 Reduced 87.84%	554 $1,000
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $8,669 - $12,633	2,318 Added 103.53%	4,557 $17,000
Q2 2023 Aug 11, 2023	SELL	$3.79 - $8.3 $5,567 - $12,192	-1,469 Reduced 39.62%	2,239 $9,000
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $33,702 - $60,195	-5,722 Reduced 60.68%	3,708 $25,000
Q4 2022 Feb 10, 2023	SELL	$5.69 - $10.07 $722 - $1,278	-127 Reduced 1.33%	9,430 $74,000
Q3 2022 Nov 10, 2022	SELL	$7.17 - $13.87 $20,083 - $38,849	-2,801 Reduced 22.67%	9,557 $91,000
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $36,595 - $82,621	6,245 Added 102.16%	12,358 $89,000
Q1 2022 May 12, 2022	SELL	$10.92 - $16.41 $22,014 - $33,082	-2,016 Reduced 24.8%	6,113 $78,000
Q4 2021 Feb 11, 2022	BUY	$15.81 - $18.99 $57,137 - $68,629	3,614 Added 80.04%	8,129 $129,000
Q3 2021 Nov 05, 2021	BUY	$12.68 - $17.79 $17,333 - $24,318	1,367 Added 43.42%	4,515 $72,000
Q2 2021 Aug 06, 2021	BUY	$12.95 - $15.41 $12,548 - $14,932	969 Added 44.47%	3,148 $43,000
Q1 2021 May 07, 2021	BUY	$14.42 - $21.39 $3,561 - $5,283	247 Added 12.78%	2,179 $31,000
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $10,085 - $11,534	-609 Reduced 23.97%	1,932 $33,000
Q3 2020 Nov 06, 2020	BUY	$17.41 - $19.89 $12,761 - $14,579	733 Added 40.54%	2,541 $46,000
Q2 2020 Aug 07, 2020	BUY	$14.43 - $19.16 $6,406 - $8,507	444 Added 32.55%	1,808 $32,000
Q1 2020 May 08, 2020	SELL	$11.67 - $22.53 $816 - $1,577	-70 Reduced 4.88%	1,364 $22,000
Q4 2019 Feb 07, 2020	SELL	$16.33 - $21.37 $1.11 Million - $1.46 Million	-68,152 Reduced 97.94%	1,434 $25,000
Q3 2019 Nov 08, 2019	SELL	$16.3 - $23.37 $450,988 - $646,601	-27,668 Reduced 28.45%	69,586 $1.41 Million
Q2 2019 Aug 09, 2019	BUY	$13.1 - $22.1 $1.27 Million - $2.15 Million	97,254 New	97,254 $0

Others Institutions Holding CHRS

# of Institutions

123

Shares Held

64.5M

Call Options Held

96.6K

Put Options Held

65.3K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $61.4M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Coherus Bio Sciences, Inc. Transaction History